| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT07491172 A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory… |
Trial sites expanded: 18 -> 21 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07758634 A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With… | Phase 1/2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05643742 | A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory… | B-cell Lymphoma | Recruiting |
| NCT07549698 | Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory… | Warm Autoimmune Hemolytic Anemia (WAIHA) | Recruiting |
| NCT07758634 | A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With… | Hypertension | Recruiting |
| Phase 1 | |||
| NCT07491172 | A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory… | Cardiovascular | Recruiting |
| NCT06925542 | A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory… | SLE (Systemic Lupus) | Recruiting |
| Not specified | |||
| NCT06208878 | A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies | Hematologic Malignancy | Enrolling by Invitation |